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Tendons among connective tissue, mainly collagen, contain also elastic fibers (EF)
made of fibrillin 1, fibrillin 2 and elastin that are broadly distributed in tendons and
represent 1–2% of the dried mass of the tendon. Only in the last years, studies on
structure and function of EF in tendons have been performed. Aim of this review is
to revise data on the organization of EF in tendons, in particular fibrillin structure and
function, and on the clinical manifestations associated to alterations of EF in tendons.
Indeed, microfibrils may contribute to tendon mechanics; therefore, their alterations
may cause joint hypermobility and contractures which have been found to be clinical
features in patients with Marfan syndrome (MFS) and Beals syndrome. The two diseases
are caused by mutations in genes FBN1 and FBN2 encoding fibrillin 1 and fibrillin 2,
respectively.
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INTRODUCTION
Tendon is a complex hierarchical structure mainly made of collagen fibrils, in which extracellular
matrix (ECM) is build up by tenocytes. More fibrils, mainly made of collagen-type-I, make fibers
which are organized in fascicles which are embedded by the endotenon sheath and all together
form the final tendon structure (Figure 1).
While collagen fibrils’ structure and mechanism have been widely studied, the remaining ECM
proteins, in particular fibrillins, in human tendons have been poorly investigated. Few data are
available on fibrillins in tendons. Elastic fibers (EF) are widely distributed among tendons. They are
made of elastin which is the core and has the capacity to recover completely from total deformation
(Kannus, 2000). It has been hypothesized that insoluble elastin provides tendon with elastic recoil
and resilience (Butler et al., 1978), as reported in blood vessels and skin (Kielty et al., 2002).
Microfibrils, mostly made of fibrillin-1 and fibrillin-2, constitute a scaffold around elastin, they
colocalize in tendon, mostly together with elastin (Mithieux andWeiss, 2005). Tropoelastin, during
elastogenesis, is deposited on microfibrils and stabilized by cross-links made up by lysyl oxidase
(Kielty, 2006). EF, are made of oxytalan fibers (OF, mostly fibrillin-1 and fibrillin-2 microfibrils)
and elastin in most tissues comprised tendons and ligaments, as shown in dogs (Ritty et al., 2002;
Smith et al., 2011). In canine tendon (flexor digitorum profundis) OF are present with different
distribution of the two fibrillins in different places, with or without elastin (Ritty et al., 2002,
2003a,b). It is known that EF organization may vary with age (Kannus, 2000).
The joint movement is made possible by the force created by the muscle and transmitted
to the bone through the tendons. Tendons are exposed to transversal, rotational, longitudinal
forces, pressures and contusions. Its internal structure protects from these forces (Józsa and
Kannus, 1997). Tendon tissue contains adhesive glycoproteins, among several non-collagenous
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FIGURE 1 | Tendon, a complex structure made of collagen fibers constituted by collagen type I and pericellular matrix (PCM) mainly made of elastic
fibers (EF): fibrillin 1 and 2, elastin, collagen type VI and others. Adapted from Grant et al. (2013).
proteins, which bind other macromolecules or cell surfaces
together (Kannus et al., 1998). Fibronectin, undulin, tenascin-C
and thrombospondin (Miller and McDevitt, 1988; Józsa et al.,
1991; Kannus et al., 1998) were detected among the tendon
belly. Vascular walls of the tendons display the presence of
laminin (Józsa et al., 1991) which is highly localized at the
myotendinous junction (Järvinen et al., 1991; Kvist et al.,
1991).
Ninety-five percent of tendon cells are tenoblasts (in youngs)
and tenocytes (in adults); the remaining 5% are chondrocytes
localized at the pressure and insertion sites, synovial cells on
the tendon surface of the tendon sheath, and vascular cells
(smooth muscle cells of the arterioles capillary, endothelial cells)
in the endotenon. In diseases, myofibroblasts, inflammatory
cells, macrophages, may be revealed in tendons (Józsa and
Kannus, 1997). Structure and diameters of tendons vary
greatly in size and at different age (de Campos Vidal and
de Carvalho, 1990). Decrease in muscle-mass and strength,
as well as alteration of tendon and bone structure are
observed during aging (Keller and Engelhardt, 2014). These
alterations are mainly due to collagen synthesis decrease,
free radicals expression increase and metabolism imbalance
in favor of catabolic activity (Tsai et al., 2011; Yu et al.,
2013).
ANIMAL MODEL DATA
Animal models have been used to characterize the structure of
tendons. Only very recently, some human tendons’ structures
have been analyzed.
Bovine Model
Analyses of deep digital flexor bovine’s tendons with no sign
of tissue damage (young adult steers, age 18–24 months) shows
that EF (elastin appears broadly distributed in tendon) are
particularly localized around tenocytes and between fascicles.
Their close localization suggests that EF, being part of
the pericellular matrix (PCM), therefore forming a network
with tenocytes, may influence cellular function. Beside, the
network enriched by EF allows tenocytes to exert mechano-
biological responses to load. EF, soon after the removal
of load, support tenocytes in going back to their previous
physiological configuration (Screen et al., 2004). ECM plays
an important rule in keeping tissue homeostasis; its disruption
may cause a spectrum of disorders (Ingber, 2003). Being strictly
associated to cells, EF may participate to cell attachment.
Fibrillin-1 binds to integrins and collagen-type-VI (Midwood
and Schwarzbauer, 2002) which is an important component
of PCM in tendon (Carvalho et al., 2006). OF link cell
to collagen-type-VI, which binds to fibrillar collagens. The
interaction and integration of EF with the surrounding matrix
is facilitated by colocalization of fibrillin-1 and perlecan in
many connective tissues including the anterior cruciate ligament
(Hayes et al., 2011). OF not only withstand mechanical
deformations but also regulate transforming growth factor
beta (TGF-β) bioavailability (Vehviläinen et al., 2009) since,
bound to fibrillin-1, it is protected from metalloproteinases
activity while, when fibrillin-1 is altered, it may be released
and exert a tissue remodeling process. According to the
mechanism of elastogenesis in which tropoelastin deposition
is performed on a microfibrils’ template, elastin in tendon
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colocalizes with fibrillin-1 (Fahrenbach et al., 1966). OF are
present in bovine tendon, as well as cruciate ligament (Smith
et al., 2011) and flexor digitorum profundus (FDP) tendon
(Ritty et al., 2002) in dog tendon. Although microfibrils
are stiffer and less extensible than elastin (Sherratt et al.,
2003) its capacity to recover from deformations confirms a
possible mechanical role similar to that of EF (Baldock et al.,
2001).
Dog Model
EF, OF and microfibril-associated glycoproteins (MAGPs)
1 and 2 distribution in the FDP tendon of dogs, was
studied and characterized by Ritty et al. (2002). The
fibrocartilaginous, avascular/tensional and insertion, three
functionally distinct regions of the FDP tendon were investigated
by immunohistochemical analysis for the five above mentioned
proteins. Both biochemical and histochemical analysis of
desmosine content, an elastin-specific cross-link, detected elastin
in all regions. Fibrillins were found not only with elastin but
also alone around internal fibroblasts. Although colocalized,
fibrillin-2 was more abundant inside the tendon while fibrillin-1
was more present in outer cell layers. MAGP-1 and MAGP-2
were highly present near the tendon insertion to bone but
also distributed along the tendon (Ritty et al., 2002). In adult
dogs with no evidence of knee osteoarthritis, Smith et al.
(2011) demonstrated that OF and EF were widespread in both
cruciate ligaments, in particular in ligament fascicles, parallel
to collagen bundles. Abundant fibrillin-1 and fibrillin-2 reach
OF, were observed. Distribution of EF indicated a possible
mechanical role in bundle reorganization following ligament
deformation. Presence and location of fibrillin-2 OF in ligament
differs from the solely fibrillin-1-containing OF previously
described in tendon suggesting differences between ligament
and tendon (Smith et al., 2011). These data obtained in dogs
suggested that OF may contribute to tendon mechanics, as
joint hypermobility and contractures found in patients with
Marfan syndrome (MFS, OMIM 154700) and Beals syndrome
(OMIM 121050), caused by mutations in the genes encoding
fibrillin-1 and fibrillin-2, respectively (Urbán and Boyd, 2000;
Gupta et al., 2002, 2004). At present, no data are available on
tissular and molecular mechanisms underlying the manner
that both syndromes affect the body’s joints. Moreover, no
data are reported in literature regarding joint hypermobility
and contractures in other fibrillinopathies (ectopia lentis,
Shprintzen–Goldberg syndrome, Weill–Marchesani syndrome,
familial or isolated aortic aneurysms) caused by alteration of
fibrillin-1 and fibrillin-2.
Mouse Model
Both collagen and intermolecular collagen cross-links
hydroxylysyl and lysylpyridinoline content of flexor digitorum
longus tendons were analyzed in Fbn2 gene null mice. Results
showed decreased collagen cross-links when compared to wild
type mice. Thus, loss of fibrillin-2, may result at the end in
dysregulation of lysyl oxidase activating enzymes and may
provide a mechanistic explanation for the reduced level of
lysyl oxidase catalyzed collagen cross-links in the Fbn2 null
mice tendon. Fbn2 null mice bone morphology, investigated
through micro computed tomography, displays a focal area
of decreased bone length in the extremities as compared to
wild type mice (Boregowda et al., 2008). Another phenotypic
trait is a ‘‘fusion’’ of some elements of the third and fourth
digits (phalanges and metacarpals; Arteaga-Solis et al., 2001).
Work from other researchers suggests that fused digits are due
to a failure of interdigital cell apoptosis and that the failure
to septate depends, at least in part, on dysregulation of bone
morphogenetic proteins (BMPs; Dahn and Fallon, 2000). During
hand development decreased bone growth, detected in the Fbn2
null mice, defines a role for the Fbn2 gene. TGF-β superfamily
members are known to be implicated in limb and skeleton
formation (Arteaga-Solis et al., 2001; Bandyopadhyay et al.,
2006); in the absence of fibrillin-2 protein, dysregulation of
growth factors may cause morphological alterations. Beside, the
skeletal phenotype of Fbn1 hypomorphic mice, where long bone
overgrowth was observed (Pereira et al., 1999), is the opposite of
the short skeletal phenotype of the Fbn2 null mice. Pereira et al.
(1999) demonstrated that homozygous Fbn1 hypomorphic mice
(mgR) produce about 25% of Fbn1 normal amount. mgR animals
present in the skeletal and aortic manifestations which mimic
those of MFS patients. Such mouse model also manifests severe
kyphosis, proposed to be due microfibril-rich ligaments’ and
tendons’ loss of tensile strength (Zhang et al., 1995). Mechanisms
of bone overgrowth in MFS have been longly discussed. In the
skeleton, gain-of-function mechanism of Fbn1 mutations has
been suggested, while loss-of-function mechanism was indicated
in cardiovascular and ocular systems (Dietz et al., 1994). Further
evidence exists suggesting that microfibrils exert negative control
on bone growth for their double role in preserving periosteal
tension and tensile strength of ligaments and tendons (Zhang
et al., 1995; Keene et al., 1997). Homozygous Fbn1 hypomorphic
mice skeletal data support the involvement of tendons in some
fibrillinopathies, as shown in MFS by Melchiorre et al. (2016).
Indeed, Zhang et al. (1995) showed that Fbn1 and Fbn2 genes
are differentially expressed during developmental stages and
various tissues and suggested that Fbn2 regulates the early EF
assembly and Fbn1 plays a prevalent role in providing structural
support.
HUMAN TENDON DATA
In human tendons, collagen bundles are made of collagens types-
I and -III. Fibril diameter may be regulated by collagen-type-
III. Type III bundles may participate to the attachment of the
periosteum or of tendons and ligaments. The distribution of
fibrillin parallels that of collagen-type-III suggesting that OF are
positioned within and around collagen-type-III fibers in human
tendon bundles (Keene et al., 1991).
Supraspinatus tendons, analyzed for the first time in humans,
show that collagen-type-VI is localized strictly together with
elastin and fibrillin-1 in the PCM region of supraspinatus tendon,
as confirmed by animal model studies (Thakkar et al., 2014).
Collagen-type-VI provides tendon’s structural integrity and,
due to its cell–matrix and matrix–matrix interactions, functions
Frontiers in Aging Neuroscience | www.frontiersin.org 3 October 2016 | Volume 8 | Article 237
Giusti and Pepe Fibrillins in Tendon
as a key regulator of matrix signals (Bonaldo et al., 1990; Kuo
et al., 1997). In human aortic media, it has been reported that
fibrillin-1 and collagen-type-VI may form bundles. These data
are of interest in relation to inherited connective tissue disorders
because it suggests that a mutation in one of the two proteins
affects the bundles (Dingemans et al., 2000).
EF display three major functions: provide mechanical
properties, including elastic recoil and resilience to tissue (Butler
et al., 1978), lead the activity of the TGF-β family (Charbonneau
et al., 2004; Feng and Derynck, 2005) and participate to handle
cell migration, survival and differentiation (Ito et al., 1997).
Fibrillins exert the structural role through the temporal and
hierarchical assembly of EF. On the other hand, fibrillins play
the instructive role by their ability of sequestering TGF-β and
BMP complexes in the ECM. It is well known that fibrillin
mutations in humans and animal models determine TGF-β
signaling perturbation (Ramirez and Sakai, 2010).
EF localize around tenocytes and between collagen fascicles
participating to the structure protection during extended periods
of loading (Ritty et al., 2002). The knowledge of the interaction
between EF and TGF-β signaling confirms the connection
demonstrated in humans through mutations in FBN1, TGFBR1
and TGFBR2 genes that are known to causeMFS and overlapping
disorder as Loeys-Dietz syndrome (LDS), familiar thoracic aorta
aneurysms and dissections (Giusti et al., 2016). It is known that
fibrillin-1 interacts with TGF-β through a protein complex (Pepe
et al., 2016).
Moreover, tenocytes distributed along tendon PCM join
to it forming an array. The array structure replies as a unit
to biomechanical and biochemical signals. PCM mechanical
properties were already found altered in other tissues. Of
particular significance are mechano-biological mechanisms,
which have been shown to be significantly altered by the
mechanical properties of PCM in other tissues (Wang, 2006;
Eyckmans et al., 2011). Concerning heart function and structure,
it was observed that in addition to furnish tensile strength
and elasticity to tissues, fibrillin-1 assemblies also regulates
cell behavior by interacting with integrin receptors and by
modulating latent TGF-β bioavailability (Ramirez and Rifkin,
2009; Ramirez and Sakai, 2010).
Tendon tears’ formation, causing damage to structure and
to mechanics of cell microenvironment, may represent the clue
for understanding pathologic modification and regeneration of
tissue (Thakkar et al., 2014). Collagen-type-VI and fibrillin-1
were more abundant than the widely distributed elastin, as
confirmed by qualitative images of large tissue tears from
torn supraspinatus tendon showing an extended disruption of
collagen-type-VI microfibrils. Beside, the presence of increased
collagen-type-III is a biomarker of great potential for healing
(Thakkar et al., 2014). Studies from other groups are required
to confirm the mechanisms causing tendon degeneration and
its relation to rotator cuff disease prognosis. To explain, it is
important to outline the tight interaction between collagens
and EF while in humans a mutation in one of these genes-
proteins display wide phenotypical heterogeneity also inside the
same family. It is reasonable to hypothesize that the damage is
extended to other proteins interacting with the mutated protein.
ELASTIC FIBERS AND PATHOLOGIES
WITH TENDON INVOLVEMENT
During EF formation in late prenatal and neonatal development,
OF constitute a three-dimensional scaffold for the assembly
of elastin (Urbán and Boyd, 2000). Insoluble elastin
provides to EF the property of elastic recoil. In addition to
the mechanical properties of resilience, EF undergo very
little turnover in normal adult tissues, with the exception
of the uterus. In adult tissue, new EF synthesis causes
accumulation of dysfunctional EF present in common
disorders such as emphysema, hypertension, actinic elastosis
(abnormal elastin accumulation) and aortic aneurysms (Kielty,
2006).
Heritable, monogenic diseases of EF are represented by
fibrillinopathies, elastinopathies and, more recently, TGF-β-
pathies (Bradley et al., 2016).
For long time congenital fingers contractures have been
considered one of the cardinal manifestations of congenital
contractural arachnodactily (CCA) and associated to muscle
alterations and to FBN2 mutations, the gene encoding fibrillin-2.
Recently, we suggested the involvement of tendons in congenital
fingers’ and toes’ contractures observed in Marfan patients,
known to display only elbows contractures (Loeys et al.,
2010), on the basis of ultrasound analysis. A reduction of
thickness of all fingers’ and toes’ tendons was detected,
suggesting an association between these findings and structural
modifications in connective tissue (Melchiorre et al., 2016). The
pilot study was performed on 13 Marfan patients diagnosed
in our Center. Since fingers and toes contractures were
reported for the first time in MFS (Melchiorre et al., 2016),
patients which are known to display elbows contractures
(Loeys et al., 2010), we searched for such manifestations in
100 Marfan patients consecutively coming at our Center for
routinary controls. Toes’ contractures and fingers’ contractures
were present in 30% and 12% of patients, respectively.
Reduced elbow contractures were found in 37% of patients
(Melchiorre et al., 2016). These data suggest the opportunity
of performing histological analysis of contractured tendons in
Marfan patients to verify the structural alteration of microfibrils
and a revision of the tendon contractures (localization,
expression) present in heritable connective tissue disorders,
since contractures are present also in other diseases such
as LDS, Ehlers-Danlos syndromes and X-linked cutis laxa.
We do not know if and in which of the above mentioned
disorders tendons are involved and if they are present
but never reported in other inherited connective tissue
disorders.
Fibrillinopathies: MFS, Neonatal MFS, CCA
MFS.Mutations in FBN1, a gene located on chromosome 15q21.1
that encodes fibrillin-1, result in the ocular, cardiovascular,
osteoarticular (among these: elbows’ contractures; Table 1),
pulmonary, skin and central nervous features characteristic of
MFS (Loeys et al., 2010; Giusti et al., 2016; Pepe et al., 2016).
FBN1 mutations also cause a group of disorders called
fibrillinopathies type 1 which include ectopia lentis,
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TABLE 1 | Tendons’ contractures, contractures and inflammation in heritable connective tissue disorders.
Connective tissue disorder/Gene Elbows Wrist Hand digits Hips Knees Feet toes
MFS/FBN1 + ? + ? ? +
nMFS/FBN1 + + ? + + ?
CCA/FBN2 + + + + + +
LDS1/TGFBR1 ? ? + ? ? +
LDS2/TGFBR2 ? ? + ? ? +
LDS3/SMAD3 ? ? + ? ? ?
LDS4/TGFB2 ? ? ? ? ? +
LDS5/TGFB3 ? ? ? ? ? +
EDS/COLs Ligamens’ and tendons’ rupture, short Achilles tendon, tendon stress/over use,
damage/rupture, tenosynovitis, tendinitis, bursitis
MFS, Marfan Syndrome; FBN1, fibrillin 1; nMFS, neonatal Marfan Syndrome; CCA, Congenital Contractural Arachnodactyly; FBN2, fibrillin 2; LDS1, Loeys-Dietz
Syndrome 1; TGFBR1, Transforming Growth Factor Beta Receptor 1; LDS2, Loeys-Dietz Syndrome 2; TGFBR2, Transforming Growth Factor Beta Receptor 2;
LDS3, Loeys-Dietz Syndrome 3; SMAD3, Mothers Against Decapentaplegic, Drosophila, Homolog of, 3; LDS4, Loeys-Dietz Syndrome 4; TGFB2, Transforming Growth
Factor Beta 2; LDS5, Loeys-Dietz Syndrome 5; TGFB3, Transforming Growth Factor Beta 3; EDS, Ehlers-Danlos Syndrome; COLs, Collagens. ? = unknown; + = reported.
Weill-Marchesani syndrome, familial ascending aortic
aneurysms and dissections, Shprintzen-Golden syndrome,
MASS phenotype, kyphoscoliosis, isolated skeletal features,
familial arachnodactyly, neonatal MFS (nMFS), the most
severe phenotype of MFS. In this last disease, FBN1 mutations
mainly positioned between the central exons 24–32, displays
the following clinical features: arachnodactyly, campodactyly
(congenital contractures of elbow, wrists, digits and toes;
Table 1), micrognathia, crumpled ears, rocker bottom feets
(arachnodactytly, overlapping toes and hypoplasia of calf
muscles), loose redundant skin creating a senile look of the
facies, severe cardiac valve insufficiency and aortic dilatation
(Buntinx et al., 1991).
A related disease, CCA (OMIM 121050), was shown
associated to mutations in FBN2, a second fibrillin gene on
chromosome 5q23.3. CCA is clinically characterized by multiple
flexion contractures (elbows, knees, hips, wrists, fingers and
toes; Table 1), arachnodactyly, severe kyphoscoliosis, abnormal
pinnae and muscular hypoplasia (Putnam et al., 1995; Gupta
et al., 2002). This work on disease-associations also contributed
to the realization that fibrillin-1 and fibrillin-2 are major
components of elastic microfibrils. The presence of multiple
flexion contractures in both nMFS and CCA has never been
investigated in terms of tendon involvement.
Recently, FBN2 variants such as FBN2 rs331079 have been
recognized as predisposing factors for Achilles tendinopathy
(AT; Khoury et al., 2015). Other gene variants have already
been found as predisposing factors for AT, among these are
variants within Collagen, type V, alpha 1 (COL5A1; Mokone
et al., 2006), matrix metallopeptidase 3 (MMP3; Raleigh et al.,
2009), TIMP Metallopeptidase Inhibitor 2 (TIMP2; El Khoury
et al., 2013), Tenascin C (TNC; Collins and Raleigh, 2009),
growth differentiation factor 5 (GDF5; Posthumus et al., 2010)
genes. Mutations in elastin encoded by ELA gene (ch7q11) are
associated to supravalvular aortic stenosis and Williams-Beuren
syndrome characterized by narrowing of whole arterial three
and increased elastinolytic activity and autosomal and recessive
cutis laxa with redundant, loose and inelastic skin, pulmonary
emphysema and aortic disease. The milder dominant form
displays also genital prolapse, diverticula, hernias, pulmonary
artery stenosis (Kielty, 2006).
TGF-β-Pathies. Loeys-Dietz Syndrome
(LDS Types 1–5)
Sincemore than 10 years,MFS has been associated with increased
TGF-β signaling (Neptune et al., 2003). Thus the molecular
mechanism underlying MFS is more complex than a single
dominant mutation in FBN1, which is due to a perturbation of
TGF-β signaling. Fibrillin-1 participates to the correct activation
of TGF-β since it is part of the large protein complex which keeps
TGF-β inactive until TGF-β links to its receptors TGFBR1 and 2
(Gelb, 2006).
LDS (OMIM 609192) is an autosomal dominant disorder of
connective tissue caused by heterozygous mutations in genes
codifying for TGFB receptor 1 or 2 (TGFBR1, LDS1 or TGFBR2,
LDS2). Its cardinal manifestations are: hypertelorism, cleft
palate or bifid uvula, arterial tortuosity and/or arterial/aortic
aneurysm. LDS displays four major clinical manifestations:
vascular ectasias and tortuosities, skeletal features, facial
dismorphology and skin manifestations. Among skeletal
features, contractures of feet (talipes equinovarus) and fingers
(campodactyly; Table 1) are common features (Loeys et al., 2005,
2006).
Mutations in other genes: TGFB2 (Lindsay et al., 2012),
TGFB3 (Matyas et al., 2014), Mothers Against Decapentaplegic,
Drosophila, Homolog of 3 (SMAD3; van de Laar et al., 2011),
all components of TGF-β signaling, have been found associated
to other diseases (LDS1, 2 and 3, respectively) in differential
diagnosis with LDS, MFS and other inherited connective tissue
disorders. Patients with mutations in TGFB2 and TGFB3 genes
display toes contractures, while patients carrying mutations in
SMAD3 present digits contractures (Table 1).
CONCLUSION
In conclusion, a lack of knowledge exists on the organization
of EF in tendons, in particular fibrillin structure and function,
and on the clinical manifestations associated to alterations of EF
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in tendons, therefore this subject needs further investigation by
the scientific community. Direct and indirect data suggest that
tendons are affected in heritable connective tissue disorders and
may play an important role in clinical features.
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